Aziz Zaanan

10.1k total citations
136 papers, 3.6k citations indexed

About

Aziz Zaanan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Aziz Zaanan has authored 136 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Oncology, 67 papers in Pulmonary and Respiratory Medicine and 57 papers in Pathology and Forensic Medicine. Recurrent topics in Aziz Zaanan's work include Colorectal Cancer Treatments and Studies (60 papers), Genetic factors in colorectal cancer (55 papers) and Gastric Cancer Management and Outcomes (53 papers). Aziz Zaanan is often cited by papers focused on Colorectal Cancer Treatments and Studies (60 papers), Genetic factors in colorectal cancer (55 papers) and Gastric Cancer Management and Outcomes (53 papers). Aziz Zaanan collaborates with scholars based in France, Italy and United States. Aziz Zaanan's co-authors include Julien Taı̈eb, Frank A. Sinicrope, Hisato Kawakami, Pierre Laurent‐Puig, Thomas Aparicio, Simon Pernot, David Malka, Pauline Afchain, Franck Bonnetain and Hélène Blons and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Aziz Zaanan

131 papers receiving 3.6k citations

Peers

Countries citing papers authored by Aziz Zaanan

Since Specialization

Citations

This map shows the geographic impact of Aziz Zaanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aziz Zaanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aziz Zaanan more than expected).

Fields of papers citing papers by Aziz Zaanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aziz Zaanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aziz Zaanan. The network helps show where Aziz Zaanan may publish in the future.

Co-authorship network of co-authors of Aziz Zaanan

This figure shows the co-authorship network connecting the top 25 collaborators of Aziz Zaanan. A scholar is included among the top collaborators of Aziz Zaanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aziz Zaanan. Aziz Zaanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	395MO Tislelizumab (TIS) + chemotherapy (CT) vs placebo (PBO) + CT in advanced or metastatic esophageal squamous cell carcinoma (ESCC): PD-L1 biomarker analysis from RATIONALE-306 2024 ·Annals of Oncology ·(unknown), Jianming Xu, Ken Kato, (unknown), Yongqian Shu, (unknown), (unknown), Lucjan Wyrwicz, David Tougeron, Karel Geboes, (unknown), Roberto Pazo-Cid, Aziz Zaanan, (unknown), Hongqian Wu, Jingwen Shi, (unknown), Sijia Yan, Harry H. Yoon	1
2	A fatal case of 5-FU toxicity despite dose adjustment in a patient with a partial DPD deficiency receiving the FLOT regimen 2024 ·European Journal of Cancer ·Aziz Zaanan, Nicolas Pallet, Céline Narjoz, Marie‐Anne Loriot, (unknown)	0
3	A systematic review of minimal length of lroximal margin in gastric adenocarcinoma resection 2023 ·Langenbeck s Archives of Surgery ·Antoine Mariani, Aziz Zaanan, Lionel Rebibo, Grégory Martin, Julien Taı̈eb, (unknown)	2
4	Prognostic value of Lynch syndrome, BRAF^V600E, and RAS mutational status in dMMR/MSI‐H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts 2023 ·Cancer Medicine ·(unknown), Frederieke H. van der Baan, Romain Cohen, Thomas Aparicio, Christelle de la Fouchardière, Thierry Lecomte, Cornelis J.A. Punt, David Sefrioui, Rik J. Verheijden, Geraldine R. Vink, G. Emerens Wensink, Aziz Zaanan, Miriam Koopman, David Tougeron, Jeanine M.L. Roodhart	7
5	Addition of trastuzumab to perioperative chemotherapy in HER2-positive gastroesophageal adenocarcinoma patients: A multicenter retrospective observational AGEO study 2023 ·Digestive and Liver Disease ·(unknown), Antoine Drouillard, Émilie Soularue, Olivier Dubreuil, Aziz Zaanan, Anthony Turpin, David Tougeron, Solène Doat, Jean‐Baptiste Bachet	1
6	Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study 2022 ·International Journal of Cancer ·(unknown), Vincent Hautefeuille, Louis de Mestier, Clélia Coutzac, Thierry Lecomte, (unknown), Pascal Artru, Anthony Turpin, Antoine Drouillard, David Malka, My‐Linh Tran‐Minh, Isabelle Trouilloud, Astrid Lièvre, Nicolas Williet, Simon Pernot, Yann Touchefeu, Julien Taı̈eb, Pascal Hammel, Aziz Zaanan	2
7	Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency 2022 ·European Journal of Cancer ·Marie-Christine Étienne-Grimaldi, Nicolas Pallet, Valérie Boige, Joseph Ciccolini, Laurent Chouchana, Chantal Barin‐Le Guellec, Aziz Zaanan, Céline Narjoz, Julien Taı̈eb, Fabienne Thomas, Marie‐Anne Loriot	19
8	Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients 2021 ·Cancers ·(unknown), Laure Hirsch, (unknown), David Malka, (unknown), Simon Pernot, Elie Marcheteau, Thibault Voron, Florence Castan, (unknown), Nadine Benhamouda, Corinne Tanchot, Éric François, François Ghiringhelli, Christelle de la Fouchardière, Aziz Zaanan, Éric Tartour, Julien Taı̈eb, Magali Terme	10
9	Bidirectional chemotherapy combining intraperitoneal docetaxel with intravenous 5-fluorouracil and oxaliplatin for patients with unresectable peritoneal metastasis from gastric cancer: the first study in Western countries 2020 ·PubMed ·Réa Lo Dico, Jean Marc Gornet, Nicola Guglielmo, Aziz Zaanan, Julien Taı̈eb, Marc Pocard	4
10	The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer 2019 ·Drugs ·Julien Taı̈eb, Andreas Jung, Andrea Sartore‐Bianchi, Marc Peeters, Jenny F. Seligmann, Aziz Zaanan, (unknown), Clara Montagut, Pierre Laurent‐Puig	53
11	Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer data 2019 ·Statistical Methods in Medical Research ·(unknown), Moreno Ursino, Peter F. Thall, Bruno Landi, Céline Lepère, Simon Pernot, Anita Burgun, Julien Taı̈eb, Aziz Zaanan, Sarah Zohar, Anne‐Sophie Jannot	7
12	Small bowel polyp resection using device‐assisted enteroscopy in Peutz‐Jeghers Syndrome: Results of a specialised tertiary care centre 2019 ·United European Gastroenterology Journal ·Guillaume Perrod, (unknown), Enrique Pérez‐Cuadrado‐Robles, Anne Berger, Hédi Benosman, Shérine Khater, (unknown), C.A. Cuénod, Aziz Zaanan, Pierre Laurent‐Puig, Gabriel Rahmi, Christophe Cellier	15
13	Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study 2018 ·British Journal of Cancer ·Simon Pernot, Olivier Dubreuil, Thomas Aparicio, Karine Le Malicot, David Tougeron, Céline Lepère, Cédric Lecaille, Lysiane Marthey, (unknown), Jean‐Baptiste Bachet, Aziz Zaanan, Julien Taı̈eb	24
14	BIABooster: Online DNA Concentration and Size Profiling with a Limit of Detection of 10 fg/μL and Application to High-Sensitivity Characterization of Circulating Cell-Free DNA 2018 ·Analytical Chemistry ·(unknown), Aurélien Bancaud, (unknown), Audrey Didelot, (unknown), Fréderic Fina, Fanny Garlan, Sonia Garrigou, C. Gaudy, Frédéric Ginot, Daniel Henaff, Pierre Laurent‐Puig, Arnaud Morin, (unknown), Laure Saïas, Valérie Taly, Pascale Tomasini, Aziz Zaanan	31
15	Immunotherapy in advanced gastric cancer, is it the future? 2018 ·Critical Reviews in Oncology/Hematology ·Clélia Coutzac, Simon Pernot, Nathalie Chaput, Aziz Zaanan	98
16	Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study) 2017 ·Clinical Cancer Research ·Fanny Garlan, Pierre Laurent‐Puig, David Sefrioui, Nathalie Siauve, Audrey Didelot, Nasrin Sarafan‐Vasseur, Pierre Michel, Géraldine Perkins, Claire Mulot, Hélène Blons, Julien Taı̈eb, Frédéric Di Fiore, Valérie Taly, Aziz Zaanan	165
17	Adjuvant FOLFOX+ cetuximab vs FOLFOX in full RAS and BRAF wild type stage III colon cancer patients: Results from the PETACC8 trial 2016 ·Annals of Oncology ·Julien Taı̈eb, Karine Le Malicot, (unknown), Josep Tabernero, Enrico Mini, Gunnar Folprecht, Jean‐Luc Van Laethem, (unknown), Claire Mulot, Serge Fratté, (unknown), (unknown), J. Thaler, Lone Nørgård Pétersen, (unknown), John Bridgewater, Géraldine Perkins, Côme Lepage, Aziz Zaanan, Pierre Laurent‐Puig	2
18	O-021 Analysis of DNA mismatch repair and clinical outcome in stage III colon cancers from patients treated with adjuvant FOLFOX +/- cetuximab in the PETACC8 and NCCTG N0147 adjuvant trials 2015 ·Annals of Oncology ·Aziz Zaanan, Qian Shi, Julien Taı̈eb, Steven R. Alberts, Thomas C. Smyrk, C. Julié, Ayman Zawadi, Josep Tabernero, Enrico Mini, Richard M. Goldberg, Gunnar Folprecht, Jean‐Luc Van Laethem, Karine Le Malicot, Daniel J. Sargent, Pierre Laurent‐Puig, Frank A. Sinicrope	1
19	FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study 2014 ·BMC Cancer ·Aziz Zaanan, Isabelle Trouilloud, (unknown), Mélanie Gauthier, (unknown), Thierry Lecomte, Thomas Aparicio, Pascal Artru, Anne Thirot‐Bidault, Fanny Joubert, (unknown), Julien Taı̈eb	27
20	Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy 2011 ·Clinical Cancer Research ·Aziz Zaanan, Jean–François Fléjou, Jean‐François Emile, (unknown), Peggy Cuillière-Dartigues, David Malka, Cédric Lecaille, Pierre Validire, Christophe Louvet, Philippe Rougier, Aimery de Gramont, Franck Bonnetain, Françoise Praz, Julien Taı̈eb	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact